About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6796 record(s)
Req # A-2021-000998
Adverse Drug Reactions (ADRs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_03817011, E2B_03542554.Organization: Health Canada
November 2021
Req # A-2021-001003
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_04017773, E2B_04415252, E2B_03992837.Organization: Health Canada
November 2021
Req # A-2021-001020
Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03595491.Organization: Health Canada
November 2021
Req # A-2021-001055
Adverse Drug Reactions (ADRs) for CROMOGLICATE SODIUM. Report numbers: E2B_03903578, 000937402.Organization: Health Canada
November 2021
Req # A-2021-001065
Adverse Drug Reaction (ADR) for KEYTRUDA. Report number: 000662315.Organization: Health Canada
November 2021
Req # A-2021-001098
Adverse Drug Reactions (ADRs). Report numbers: 000956788, 000956577, 000953894, 000954540, 000954813, 000955084, 000955192, 000955225.Organization: Health Canada
November 2021
Req # A-2021-001114
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_02615649.Organization: Health Canada
November 2021
Req # A-2021-001120
Adverse Drug Reactions (ADRs) for CROMOGLICATE SODIUM. Report numbers: 946232, E2B_03903578, E2B_03764500, 935799, 937402.Organization: Health Canada
November 2021
Req # A-2021-001123
Adverse Drug Reaction (ADR) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: 934426.Organization: Health Canada
November 2021
Req # A-2021-001124
Adverse Drug Reaction (ADR). Report number: 000953907.Organization: Health Canada
November 2021